Novartis Needs U.S. Security Nod for Endocyte Under New Rules

(Bloomberg) -- Novartis AG needs approval from U.S. national security officials for its planned takeover of Endocyte Inc., among the first deals to fall under expanded rules for reviewing foreign t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.